Its benefits extend further, with evidence supporting its ability to protect the heart from serious cardiovascular events , improve outcomes for those with heart failure , and reduce kidney-related complications in people with diabetes and chronic kidney disease
2020 Jul-Aug;75-76:110771
Pharmacokinetics Absorption The absolute bioavailability of tesamorelin after subcutaneous administration of a 2 mg dose was determined to be less than 4% in healthy adult subjects
Then we have the ITT data
Tirzepatide, or Mounjaro, is a dual agonist, meaning that it also works on GIP receptors
Serious side effects for both medications are rare but include pancreatitis, gallbladder disease, and (in animal studies only) medullary thyroid carcinoma